HTA

Health technology assessment (HTA)

Ensuring efficiency and effectiveness of Joint Clinical Assessment (JCA) – Wang 2025

Background: This study explored the readiness and strategic considerations of companies and key stakeholders for the implementation of the Joint Clinical Assessment (JCA) under the European Health Technology Assessment [...]

2025-04-15T09:09:03+00:00April 15th, 2025|Tags: , |

CIRS RD Briefing 98 – European HTA trends: HTA outcomes and timelines across seven markets 2019-2023

This R&D Briefing presents data from HTADock, an ongoing CIRS metrics study that collects publicly available data on new active substances (NASs) appraised by key international HTA agencies. It [...]

Frequency and Variation of Clock-Stop During EMA Assessment for Oncology Products – Implication on JCA Timelines

Objectives: The implementation act adopted for the HTA Regulation (HTAR) defined the timelines of scoping, submission and assessment and output of Joint Clinical Assessment (JCA), which will be in [...]

2024-11-28T14:31:01+00:00November 28th, 2024|Tags: , , , |

CIRS RD Briefing 96 – Review of HTA outcomes and timelines in Australia, Canada and the UK 2019-2023

This R&D Briefing presents data from HTADock, an ongoing metrics study that collects publicly available data on new active substances (NASs) appraised by key international HTA agencies. It focuses [...]

Go to Top